We recently compiled a list of the 9 Must-See AI News Updates That Are Trending on Wall Street. In this article, we are going ...

Research analysts at Cantor Fitzgerald reduced their FY2025 earnings estimates for Amgen in a research note issued to ...

Cantor Fitzgerald lowered their FY2025 earnings per share (EPS) estimates for CVRx in a research report issued on Wednesday, ...

We recently published a list of 9 Trending AI News Updates on Wall Street’s Radar. In this article, we are going to take a look at where AST SpaceMobile, Inc.

Cantor Fitzgerald reaffirmed its Overweight rating on Neurocrine Biosciences stock (NASDAQ:NBIX) with a consistent price target of $170.00. Currently trading at $150.51, the stock has shown strong ...

As previously reported last night, Cantor Fitzgerald analyst Colin Canfield initiated coverage of five Government Technology & Space, or ...

Will the Senate GOP confirm controversial picks like Tulsi Gabbard and RFK Jr.? Here’s the hearings schedule and list of ...

In a report released yesterday, Matthew Prisco from Cantor Fitzgerald maintained a Buy rating on Onto Innovation (ONTO – Research Report), with ...

It’s not that the Trump administration is anti-Goldman Sachs, sources say, but rather there just isn’t as much talent to take ...

LKQ Corporation (LKQ) filed suit against Robert Rutledge, its former plant manager, in the U.S. District Court for the Northern District ...